Pharma JV Joins Bid To Revoke Janssen's Stelara Patent
Two more pharmaceutical companies have pushed a London court to revoke the patent of Janssen Biotech Inc. on its immunosuppressive drug Stelara in a bid to open up the market to biosimilar...To view the full article, register now.
Already a subscriber? Click here to view full article